Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1951 1
1958 1
1959 1
1960 1
1964 1
1965 1
1969 2
1972 1
1973 1
1977 2
1987 3
1989 4
1990 2
1991 2
1992 2
1993 2
1994 1
1995 1
1996 1
1997 2
1998 2
2000 5
2001 3
2002 2
2003 2
2004 6
2005 3
2006 3
2007 8
2008 9
2009 6
2010 8
2011 8
2012 9
2013 14
2014 13
2015 7
2016 11
2017 9
2018 13
2019 12
2020 21
2021 24
2022 13
2023 21
2024 6
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Results by year

Filters applied: . Clear all
Page 1
Hemorrhagic stroke.
Montaño A, Hanley DF, Hemphill JC 3rd. Montaño A, et al. Handb Clin Neurol. 2021;176:229-248. doi: 10.1016/B978-0-444-64034-5.00019-5. Handb Clin Neurol. 2021. PMID: 33272397 Review.
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Johnston SC, et al. N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766750 Free PMC article. Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Morquio A syndrome: diagnosis and current and future therapies.
Tomatsu S, Yasuda E, Patel P, Ruhnke K, Shimada T, Mackenzie WG, Mason R, Thacker MM, Theroux M, Montaño AM, Alméciga-Díaz CJ, Barrera LA, Chinen Y, Sly WS, Rowan D, Suzuki Y, Orii T. Tomatsu S, et al. Among authors: montano am. Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1(0 1):141-51. Pediatr Endocrinol Rev. 2014. PMID: 25345096 Free PMC article. Review.
Brief Interventions for Cannabis Using Adolescents.
Winters KC, Waldron H, Hops H, Ozechowski T, Montano A. Winters KC, et al. Among authors: montano a. Psychiatr Clin North Am. 2023 Dec;46(4):761-773. doi: 10.1016/j.psc.2023.03.010. Psychiatr Clin North Am. 2023. PMID: 37879837 Review.
Brief Interventions for Cannabis Using Adolescents.
Winters KC, Waldron H, Hops H, Ozechowski T, Montano A. Winters KC, et al. Among authors: montano a. Child Adolesc Psychiatr Clin N Am. 2023 Jan;32(1):127-140. doi: 10.1016/j.chc.2022.06.004. Child Adolesc Psychiatr Clin N Am. 2023. PMID: 36410899 Review.
Targeted genome editing in acute lymphoblastic leukemia: a review.
Montaño A, Forero-Castro M, Hernández-Rivas JM, García-Tuñón I, Benito R. Montaño A, et al. BMC Biotechnol. 2018 Jul 17;18(1):45. doi: 10.1186/s12896-018-0455-9. BMC Biotechnol. 2018. PMID: 30016959 Free PMC article. Review.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Prat A, Saura C, Pascual T, Hernando C, Muñoz M, Paré L, González Farré B, Fernández PL, Galván P, Chic N, González Farré X, Oliveira M, Gil-Gil M, Arumi M, Ferrer N, Montaño A, Izarzugaza Y, Llombart-Cussac A, Bratos R, González Santiago S, Martínez E, Hoyos S, Rojas B, Virizuela JA, Ortega V, López R, Céliz P, Ciruelos E, Villagrasa P, Gavilá J. Prat A, et al. Among authors: montano a. Lancet Oncol. 2020 Jan;21(1):33-43. doi: 10.1016/S1470-2045(19)30786-7. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838010 Clinical Trial.
245 results